Related Experiment Video
Updated: Jan 13, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Development of the Belief Scale of Conducting Standardized Prevention and Treatment of Allergic Diseases for Medical
Ke-Ying Zuo1, Liang-Ming Li1, Xing-Ming Li2
1Department of Epidemiology and Biostatistics,Institute of Basic Medical Sciences,CAMS and PUMC,Beijing 100005,China.
Abstract:
Objective To develop the belief scale of conducting the standardized prevention and treatment of allergic diseases for medical practitioners,thus assessing their beliefs of conducting the standardized approaches and providing an evaluation tool for the further research. Methods With the Health Belief Model as the theoretical framework,the dimensions and items of the scale were preliminarily developed through literature review and semi-structured interviews.The Delphi method was used to conduct 2 rounds of consultation with 25 experts for revising the scale.The positive coefficient,authority coefficient,degree of concentration,and degree of coordination were calculated as the criteria to build the scale. Results The recovery rates of the two rounds were 100% and 96%.The authority coefficients were 0.838 in both rounds,and the Kendall's coefficients of concordance were 0.127(χ2=145.803,P<0.001) and 0.084(χ2=78.520,P<0.001).The final scale was developed,encompassing 39 items in 6 dimensions. Conclusion The belief scale of conducting standardized prevention and treatment of allergic diseases for medical practitioners is preliminarily developed via the Delphi method,which demonstrates high rationality.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Allergic Reactions
Allergic Drug Reactions
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Preclinical Development: Overview

